Neuroblastoma

Showing 51 - 75 of 393

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Neuroblastoma Trial in United States (Ceritinib, dasatinib, sorafenib)

Recruiting
  • Neuroblastoma
  • Birmingham, Alabama
  • +23 more
Sep 26, 2022

Pediatric Cancer, Hodgkin Disease, CD30-Positive DLBCL Trial in Milwaukee (anti-CD30 Bispecific Antibody-armed

Not yet recruiting
  • Pediatric Cancer
  • +11 more
  • anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC)
  • Milwaukee, Wisconsin
    Children's Wisconsin
Sep 14, 2022

Ganglioneuroblastoma, Neuroblastoma Trial in Canada, Puerto Rico, United States (procedure, drug, biological, radiation)

Recruiting
  • Ganglioneuroblastoma
  • Neuroblastoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +18 more
  • Birmingham, Alabama
  • +158 more
Sep 14, 2022

Neuroblastoma Trial in Worldwide (GM-CSF + Naxitamab)

Recruiting
  • Neuroblastoma
  • GM-CSF + Naxitamab
  • Gainesville, Florida
  • +22 more
Aug 29, 2022

Neuroblastoma Trial in United States (Tolcapone, Oxaliplatin)

Terminated
  • Neuroblastoma
  • Little Rock, Arkansas
  • +8 more
Aug 23, 2022

Ewing Sarcoma, Solid Tumors, Rhabdoid Tumor Trial in Worldwide (Palbociclib, Temozolomide, Irinotecan)

Recruiting
  • Ewing Sarcoma
  • +6 more
  • Birmingham, Alabama
  • +83 more
Aug 19, 2022

Neuroblastoma Trial in United States (18F-MFBG)

Recruiting
  • Neuroblastoma
  • Los Angeles, California
  • +7 more
Aug 18, 2022

Neuroblastoma Trial in Worldwide (LY3295668 Erbumine, Topotecan, Cyclophosphamide)

Active, not recruiting
  • Neuroblastoma
  • LY3295668 Erbumine
  • +2 more
  • San Francisco, California
  • +21 more
Aug 17, 2022

Ganglioneuroblastoma, Nodular, Neuroblastoma Trial in Worldwide (Dinutuximab, Irinotecan, Isotretinoin)

Active, not recruiting
  • Ganglioneuroblastoma, Nodular
  • Neuroblastoma
  • Dinutuximab
  • +4 more
  • Mesa, Arizona
  • +77 more
Aug 17, 2022

Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma Trial in Worldwide (Carboplatin,

Recruiting
  • Ganglioneuroblastoma
  • +3 more
  • Birmingham, Alabama
  • +219 more
Aug 17, 2022

International PPB/DICER1 Registry

Recruiting
  • Pleuropulmonary Blastoma
  • +14 more
    • Minneapolis, Minnesota
      Children's Minnesota
    Aug 16, 2022

    Collecting and Storing Tissue From Young Patients With Cancer

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +13 more
    • Cytology Specimen Collection Procedure
    • Laboratory Biomarker Analysis
    • Birmingham, Alabama
    • +68 more
    Aug 4, 2022

    Neuroblastoma, Osteosarcoma, Other Solid Tumor Cancers Trial in New York (Humanized 3F8 Bispecific Antibody, Blood draw)

    Terminated
    • Neuroblastoma
    • +2 more
    • Humanized 3F8 Bispecific Antibody
    • Blood draw
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 11, 2022

    Neuroblastoma, Childhood Metastatic Pheochromocytoma Trial in Philadelphia (131 I-Metaiodobenzylguanidine (131 I-MIBG), 131

    Available
    • Neuroblastoma
    • Childhood Metastatic Pheochromocytoma
    • 131 I-Metaiodobenzylguanidine (131 I-MIBG)
    • 131 I-MIBG
    • Philadelphia, Pennsylvania
      The Children's Hospital of Philadelphia
    Jul 11, 2022

    Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)

    Recruiting
    • Pediatric Solid Tumor
    • +15 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Jun 30, 2022

    Neuroblastoma Trial in New York (Hu3F8, GM-CSF, Isotretinoin)

    Active, not recruiting
    • Neuroblastoma
    • Hu3F8
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 1, 2022

    Neuroblastoma Trial in Guangzhou (Anti Thymocyte Globulin, Fludarabine, Cyclophosphamide injection)

    Not yet recruiting
    • Neuroblastoma
    • Anti Thymocyte Globulin
    • +10 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    Jun 29, 2022

    Neuroblastoma Trial (Topotecan, Temozolomide, Ribociclib)

    Not yet recruiting
    • Neuroblastoma
    • (no location specified)
    Jun 17, 2022

    Neuroblastoma Trial in Los Angeles (Dinutuximab with Chemotherapy)

    Not yet recruiting
    • Neuroblastoma
    • Dinutuximab with Chemotherapy
    • Los Angeles, California
      Childrens Hospital Los Angeles
    Jun 13, 2022

    Neuroblastoma Trial in Canada, United States (131I-MIBG, Vincristine, Irinotecan)

    Completed
    • Neuroblastoma
    • 131I-MIBG
    • +3 more
    • Los Angeles, California
    • +13 more
    May 16, 2022

    Neuroblastoma Biology Study

    Recruiting
    • Neuroblastoma
      • Los Angeles, California
      • +13 more
      May 18, 2022

      Neuroblastoma Trial in New York (anti-GD2 murine IgG3 mAb 3F8)

      Completed
      • Neuroblastoma
      • anti-GD2 murine IgG3 monoclonal antibody 3F8
      • New York, New York
        Memorial Sloan-Kettering Cancer Center
      Apr 21, 2022

      Familial Investigations of Childhood Cancer Predisposition

      Recruiting
      • Acute Leukemia
      • +45 more
        • Memphis, Tennessee
          St. Jude Children's Research Hospital
        May 11, 2022

        Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second

        Recruiting
        • Pediatric Solid Tumor
        • +15 more
        • second generation 4-1BBζ EGFR806-EGFRt
        • second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
        • Seattle, Washington
          Seattle Children's Hospital
        May 2, 2022